Finding and Connecting the World’s Displaced Communities with Matilde Gattoni

To see more of her dispatches from around the world, follow @matildegattoni on Instagram.

Matilde Gattoni (@matildegattoni) has her #EyesOn the world’s displaced communities. Working across the Middle East, Asia and Africa, the Italian photographer’s stories are driven by realizations she makes on the ground. “I was very surprised to learn that there are 13 countries along the coast of West Africa that are seriously being affected by the consequences of climate change,” she says. “One day we were in a very small village in Ghana, and there was a very severe high tide. And in just one night, that village lost 5 meters [16 feet] of land.”

Matilde intentionally covers a broad range of countries and scenarios to highlight the interconnectedness of environmental issues. “Climate change in [another] part of the world is caused by the fact that the icebergs are melting north of Europe,” she explains. Some observers have commented that she seems especially focused on women, but Matilde sees it differently: “It’s often women that fight for their lives, the survival of their families. ‘What if this was me? What if this was my life?’ This is what I really hope that readers see in my pictures.”
American Pastor Who Helped Uganda Create ‘Kill The Gays’ Law Will Be Tried For Crimes Against Humanity
National embarrassment Scott Lively finally lost his last appeal and will now face crimes against humanity charges.

Muhammad Ali speaks the truth… this is still relevant.
End in sight for HIV?
There is new hope of finally defeating HIV - a vaccine to prevent the disease to be tested in South Africa in November.

South African scientists have been testing the newly modified vaccine for two years in this country: first to ensure its safety and then to see if it activated the immune system. Yesterday, at the HIV Vaccine Trial Network conference in Washington DC, it was announced that the tests had been successful and a three-year trial involving 5700 people aged 18 to 35 will kick off in November. Results are expected by 2020.

The vaccine is so far advanced in testing that it is likely to be the first marketed. Glenda Gray, head of the Medical Research Council, who will lead the trial, said it was “great news”. Current prevention regimens require strict daily adherence to treatment, which tends to lessen compliance .